EUVIMEDEUVIMED entdecken
Crossref

Dual silencing of tumor-intrinsic VISTA and CTLA-4 stimulates T-cell mediated immune responses and inhibits MCF7 breast cancer development

Negar Hosseinkhani, Nima Hemmat, Elham Baghbani, Amir Baghbanzadeh, Tohid Kazemi, Ahad Mokhtarzadeh, Mahdi Jafarlou, Mohammad Amin Doustvandi, Behzad Baradaran

Gene · 2024

DOI: 10.1016/j.gene.2023.148043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gene, 2024. Verfasst von Negar Hosseinkhani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Breast Neoplasms, CTLA-4 Antigen, T-Lymphocytes, B7 Antigens. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Tabriz University of Medical Sciences, National Institute for Medical Research Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: As inhibitory immune checkpoint molecules, cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) and V-domain Ig suppressor of T-cell activation (VISTA) can be expressed in tumoral cells and facilitate immune evasion of tumoral cells. Herein, we studied the significance of tumor-intrinsic CTLA-4 and VISTA silencing in tumor development and inflammatory factors expression in a co-culture system with MCF7 and T-cells. METHODS: MCF7 cells were transfected with 60 pmol of CTLA-siRNA, VISTA-siRNA, and dual VISTA-/CTLA-4-siRNA. The MTT assay was performed to study the effect of CTLA-4 and VISTA knockdown on the viability of MCF7 cells. Colony formation and wound-healing assays were performed to investigate the effect of CTLA-4 and VISTA silencing on the clonogenicity and migration of MCF7 cells. Flow cytometry was used to study the significance of CTLA-4 and VISTA knockdown on the apoptosis and cell cycle of MCF7 cells. Also, a co-culture system with MCF7 and T-cells was developed to study the expression levels of IL-2, IFN-γ, TNF-α, TGF-β, and IL-10 following CTLA-4 and VISTA knockdown. The expression levels of caspase3, Bax, Bcl2, and MMP-9 were also investigated using quantitative real-time PCR. Finally, the TCGA Breast Cancer and GSE45827 datasets were analyzed to study the potential prognostic values of VISTA and CTLA-4, their expression difference in luminal A breast cancer and non-tumoral tissues, and their correlation in luminal A breast cancer tissues. RESULTS: Combined knockdown of tumor-intrinsic VISTA and CTLA-4 is superior in upregulating IL-2, IFN-γ, and TNF-α, downregulating TGF-β and IL-10 in T lymphocytes. Also, the combined silencing arrests the cell cycle at the sub-G1 phase, decreases migration, inhibits clonogenicity, and reduces cell viability of MCF7 cells. This combined treatment upregulates caspase 9 and BAX and downregulates MMP-9 in MCF7 cells. Our in-silico results have demonstrated a significant positive correlation between CTLA-4 and VISTA in luminal A breast cancer. CONCLUSION: The additive effect of the combined knockdown of tumor-intrinsic VISTA and CTLA-4 can substantially upregulate pro-inflammatory factors, downregulate anti-inflammatory factors, and inhibit tumor development in MCF7 cells. The significant positive correlation between VISTA and CTLA-4 in luminal A breast cancer might support the idea that a network of inhibitory immune checkpoint molecules regulates anti-tumoral immune responses; thus, combinational immune checkpoint molecules blockade can be suggested.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCTLA-4 AntigenT-LymphocytesB7 AntigensFemaleHumansbcl-2-Associated X ProteinImmune Checkpoint ProteinsInterleukin-10Interleukin-2Lymphocyte ActivationMatrix Metalloproteinase 9MCF-7 CellsRNA, Small InterferingTransforming Growth Factor betaTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

Breast cancerCTLA-4ImmunotherapyInhibitory immune checkpointVISTA

Substanzen

bcl-2-Associated X ProteinCTLA-4 AntigenImmune Checkpoint ProteinsInterleukin-10Interleukin-2Matrix Metalloproteinase 9RNA, Small InterferingTransforming Growth Factor betaTumor Necrosis Factor-alphaVSIR protein, human

Autor:innen und Institutionen

  • Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: baradaranb@tbzmed.…

Förderung

  • Tabriz University of Medical Sciences
  • National Institute for Medical Research Development

Zitieren

APA

Hosseinkhani, N., Hemmat, N., Baghbani, E., Baghbanzadeh, A., Kazemi, T., Mokhtarzadeh, A., Jafarlou, M., Amin Doustvandi, M., & Baradaran, B. (2024). Dual silencing of tumor-intrinsic VISTA and CTLA-4 stimulates T-cell mediated immune responses and inhibits MCF7 breast cancer development. Gene. https://doi.org/10.1016/j.gene.2023.148043

Vancouver

Hosseinkhani N, Hemmat N, Baghbani E, Baghbanzadeh A, Kazemi T, Mokhtarzadeh A, et al. Dual silencing of tumor-intrinsic VISTA and CTLA-4 stimulates T-cell mediated immune responses and inhibits MCF7 breast cancer development. Gene. 2024. doi:10.1016/j.gene.2023.148043

BibTeX
@article{Hosseinkhani2024,
  author = {Hosseinkhani, Negar and Hemmat, Nima and Baghbani, Elham and Baghbanzadeh, Amir and Kazemi, Tohid and Mokhtarzadeh, Ahad and Jafarlou, Mahdi and Amin Doustvandi, Mohammad and Baradaran, Behzad},
  title = {Dual silencing of tumor-intrinsic VISTA and CTLA-4 stimulates T-cell mediated immune responses and inhibits MCF7 breast cancer development},
  journal = {Gene},
  year = {2024},
  doi = {10.1016/j.gene.2023.148043}
}
Kostenlos starten →